ArticleGynecologic oncology reports2025

Homologous recombination status drives disease-free survival in patients with advanced ovarian cancer undergoing hyperthermic intraperitoneal chemotherapy at the time of interval debulking surgery.

Khrystyna Levytska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.